These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 18929499)

  • 21. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
    Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
    Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
    Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
    Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance.
    Casano-Sancho P; López-Bermejo A; Fernández-Real JM; Monrós E; Valls C; Rodríguez-González FX; Ricart W; Ibáñez L
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):129-35. PubMed ID: 16430709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
    Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
    Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Birth size, postnatal growth and growth during growth hormone treatment in small-for-gestational-age children: associations with IGF1 gene polymorphisms and haplotypes?
    Ester WA; van Meurs JB; Arends NJ; Uitterlinden AG; de Ridder MA; Hokken-Koelega AC
    Horm Res; 2009; 72(1):15-24. PubMed ID: 19571555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of IGF-binding protein-3 as a potential marker of intra-uterine growth restriction.
    Baker Méio MD; Lopes Moreira ME; Sichieri R; Moura AS
    J Perinat Med; 2009; 37(6):689-93. PubMed ID: 19591553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Mullerian hormone in short girls born small for gestational age and the effect of growth hormone treatment.
    Lem AJ; Boonstra VH; Renes JS; Breukhoven PE; de Jong FH; Laven JS; Hokken-Koelega AC
    Hum Reprod; 2011 Apr; 26(4):898-903. PubMed ID: 21227938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F; Hokken-Koelega A
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
    Woods KA; van Helvoirt M; Ong KK; Mohn A; Levy J; de Zegher F; Dunger DB
    Pediatr Res; 2002 Jan; 51(1):76-80. PubMed ID: 11756643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
    Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ghrelin in small-for-gestational age (SGA) newborn babies: a cross-sectional study.
    Méndez-Ramírez F; Barbosa-Sabanero G; Romero-Gutiérrez G; Malacara JM
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):41-6. PubMed ID: 18419783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.
    Binder G; Seidel AK; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Eggermann T; Ranke MB
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1402-7. PubMed ID: 18230663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.